Literature DB >> 33392050

Haematological indices of sickle cell patients with chronic leg ulcers on compression therapy.

Oluwatoyin A Babalola1, Ayodele Ogunkeyede2, Abayomi B Odetunde1, Foluke Fasola3, Anthony A Oni4, Chinedum P Babalola1,5, Adeyinka G Falusi1,5.   

Abstract

BACKGROUND: Recurrent chronic leg ulcers and its are morbidities associated with sickle cell anaemia (SCA). Compression therapy increases the rate of healing of these ulcers and also decreases the rate of recurrence.
OBJECTIVE: This study evaluated the haematological parameters of patients with SCA and chronic leg ulcers placed on high compression bandaging to provide data for improved ulcer management and prevention.
METHODS: Eighteen patients with SCA and chronic leg ulcers were recruited for treatment by compression therapy in Ibadan, Nigeria, from March to June 2015. Eighteen SCA patients with no history of chronic leg ulcers were age and sex matched and recruited as controls. Blood samples, wound biopsies and swabs were collected at different time points for full blood count, microbiology, culture and antimicrobial susceptibility tests. Haemoglobin variants were quantified by high performance liquid chromatography. Fasting blood sugar was tested for leg ulcer patients to determine diabetic status.
RESULTS: Ulcers ranged from 0.5 cm2 to 416 cm2 (median: 38.4 cm2). Post-intervention ulcer size ranged from 0.0 cm2 to 272 cm2 (median: 18.6 cm2, p < 0.001); four ulcers completely healed. Compared to the control group, haematological indices at commencement of treatment were more severe in leg ulcer patients (p = 0.02). No patients with chronic leg ulcer was diabetic. Microorganisms isolated from the leg ulcers include Pseudomonas aeruginosa, Staphylococcus aureus, Proteus sp., Escherichia coli and Klebsiella oxytoca.
CONCLUSION: Measures to improve haematological parameters during leg ulcer treatment in SCA patients should be taken to aid wound healing.
© 2020. The Authors.

Entities:  

Keywords:  chronic leg ulcer; compression therapy; haematological parameters; sickle cell anaemia; wound healing

Year:  2020        PMID: 33392050      PMCID: PMC7756931          DOI: 10.4102/ajlm.v9i1.1037

Source DB:  PubMed          Journal:  Afr J Lab Med        ISSN: 2225-2002


  38 in total

1.  Leg ulcers in sickle cell disease.

Authors:  Caterina P Minniti; James Eckman; Paola Sebastiani; Martin H Steinberg; Samir K Ballas
Journal:  Am J Hematol       Date:  2010-10       Impact factor: 10.047

2.  Healing of refractory leg ulcer in a patient with thalassemia intermedia and hypercoagulability after 14 years of unresponsive therapy.

Authors:  Carina Levin; Ariel Koren
Journal:  Isr Med Assoc J       Date:  2011-05       Impact factor: 0.892

3.  Chronic leg ulceration in homozygous sickle cell disease: the role of venous incompetence.

Authors:  Andrea Clare; Michael FitzHenley; June Harris; Ian Hambleton; Graham R Serjeant
Journal:  Br J Haematol       Date:  2002-11       Impact factor: 6.998

4.  Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway.

Authors:  Vikki G Nolan; Adeboye Adewoye; Clinton Baldwin; Ling Wang; Qianli Ma; Diego F Wyszynski; John J Farrell; Paola Sebastiani; Lindsay A Farrer; Martin H Steinberg
Journal:  Br J Haematol       Date:  2006-06       Impact factor: 6.998

Review 5.  Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery ® and the American Venous Forum.

Authors:  Thomas F O'Donnell; Marc A Passman; William A Marston; William J Ennis; Michael Dalsing; Robert L Kistner; Fedor Lurie; Peter K Henke; Monika L Gloviczki; Bo G Eklöf; Julianne Stoughton; Sesadri Raju; Cynthia K Shortell; Joseph D Raffetto; Hugo Partsch; Lori C Pounds; Mary E Cummings; David L Gillespie; Robert B McLafferty; Mohammad Hassan Murad; Thomas W Wakefield; Peter Gloviczki
Journal:  J Vasc Surg       Date:  2014-06-25       Impact factor: 4.268

6.  Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S.

Authors:  R L Nagel; R M Bookchin; J Johnson; D Labie; H Wajcman; W A Isaac-Sodeye; G R Honig; G Schilirò; J H Crookston; K Matsutomo
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

Review 7.  Use of molecular techniques to study microbial diversity in the skin: chronic wounds reevaluated.

Authors:  C E Davies; M J Wilson; K E Hill; P Stephens; C M Hill; K G Harding; D W Thomas
Journal:  Wound Repair Regen       Date:  2001 Sep-Oct       Impact factor: 3.617

8.  Recombinant human erythropoietin induced rapid healing of a chronic leg ulcer in a patient with sickle cell disease.

Authors:  A K al-Momen
Journal:  Acta Haematol       Date:  1991       Impact factor: 2.195

9.  Venous incompetence, poverty and lactate dehydrogenase in Jamaica are important predictors of leg ulceration in sickle cell anaemia.

Authors:  V Cumming; L King; R Fraser; G Serjeant; M Reid
Journal:  Br J Haematol       Date:  2008-05-08       Impact factor: 6.998

Review 10.  Clinical biomarkers in sickle cell disease.

Authors:  Ghazi A Damanhouri; Jummanah Jarullah; Samy Marouf; S I Hindawi; Gohar Mushtaq; Mohammad A Kamal
Journal:  Saudi J Biol Sci       Date:  2014-09-18       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.